
Stephen W. Smoot
Examiner (ID: 5783, Phone: (571)272-1698 , Office: P/2813 )
| Most Active Art Unit | 2813 |
| Art Unit(s) | 2813 |
| Total Applications | 1918 |
| Issued Applications | 1746 |
| Pending Applications | 33 |
| Abandoned Applications | 142 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16917682
[patent_doc_number] => 20210190774
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-24
[patent_title] => COMPOSITIONS AND METHODS FOR THE DETECTION AND MOLECULAR PROFILING OF MEMBRANE BOUND VESICLES
[patent_app_type] => utility
[patent_app_number] => 16/954112
[patent_app_country] => US
[patent_app_date] => 2018-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17695
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16954112
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/954112 | COMPOSITIONS AND METHODS FOR THE DETECTION AND MOLECULAR PROFILING OF MEMBRANE BOUND VESICLES | Dec 17, 2018 | Pending |
Array
(
[id] => 14464801
[patent_doc_number] => 20190184040
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-20
[patent_title] => Targeted Macrocyclic Agents for Dual Modality PET and MRI Imaging of Cancer
[patent_app_type] => utility
[patent_app_number] => 16/222364
[patent_app_country] => US
[patent_app_date] => 2018-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7421
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16222364
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/222364 | Targeted Macrocyclic Agents for Dual Modality PET and MRI Imaging of Cancer | Dec 16, 2018 | Abandoned |
Array
(
[id] => 16053365
[patent_doc_number] => 20200188537
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-18
[patent_title] => Methods And Apparatuses For The Detection Of Disease Such As Cancer
[patent_app_type] => utility
[patent_app_number] => 16/221429
[patent_app_country] => US
[patent_app_date] => 2018-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13857
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 166
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16221429
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/221429 | Methods And Apparatuses For The Detection Of Disease Such As Cancer | Dec 13, 2018 | Abandoned |
Array
(
[id] => 14700089
[patent_doc_number] => 10377778
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-08-13
[patent_title] => Lead and thorium compounds
[patent_app_type] => utility
[patent_app_number] => 16/219072
[patent_app_country] => US
[patent_app_date] => 2018-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 13432
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16219072
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/219072 | Lead and thorium compounds | Dec 12, 2018 | Issued |
Array
(
[id] => 16326889
[patent_doc_number] => 20200297854
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-24
[patent_title] => NANOTHERAPEUTICS FOR DRUG TARGETING
[patent_app_type] => utility
[patent_app_number] => 16/216447
[patent_app_country] => US
[patent_app_date] => 2018-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 51000
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16216447
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/216447 | NANOTHERAPEUTICS FOR DRUG TARGETING | Dec 10, 2018 | Abandoned |
Array
(
[id] => 16686882
[patent_doc_number] => 20210069357
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-11
[patent_title] => NEW DAZA CHELATORS AS LIGANDS IN LIVER IMAGING
[patent_app_type] => utility
[patent_app_number] => 16/771696
[patent_app_country] => US
[patent_app_date] => 2018-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7836
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16771696
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/771696 | DAZA chelators as ligands in liver imaging | Dec 9, 2018 | Issued |
Array
(
[id] => 14105295
[patent_doc_number] => 20190094323
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-28
[patent_title] => SYSTEMS AND METHODS OF DETECTING INTERSTITIAL CYSTITIS
[patent_app_type] => utility
[patent_app_number] => 16/205654
[patent_app_country] => US
[patent_app_date] => 2018-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19436
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -34
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16205654
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/205654 | Systems and methods of detecting interstitial cystitis | Nov 29, 2018 | Issued |
Array
(
[id] => 14306545
[patent_doc_number] => 20190142976
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-16
[patent_title] => COMPOSITIONS AND METHODS FOR ASSESSING GUT FUNCTION
[patent_app_type] => utility
[patent_app_number] => 16/200353
[patent_app_country] => US
[patent_app_date] => 2018-11-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6347
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16200353
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/200353 | Compositions and methods for assessing gut function | Nov 25, 2018 | Issued |
Array
(
[id] => 14099345
[patent_doc_number] => 20190091348
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-28
[patent_title] => COMPOSITIONS AND METHODS FOR ASSESSING GUT FUNCTION
[patent_app_type] => utility
[patent_app_number] => 16/200311
[patent_app_country] => US
[patent_app_date] => 2018-11-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6348
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16200311
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/200311 | Compositions and methods for assessing gut function | Nov 25, 2018 | Issued |
Array
(
[id] => 16837975
[patent_doc_number] => 20210145987
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-20
[patent_title] => PHARMACEUTICAL COMPOSITION COMPRISING TETROFOSMIN AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/627466
[patent_app_country] => US
[patent_app_date] => 2018-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4901
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16627466
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/627466 | Pharmaceutical composition comprising tetrofosmin and pharmaceutically acceptable salts thereof | Nov 21, 2018 | Issued |
Array
(
[id] => 14637179
[patent_doc_number] => 10363318
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-07-30
[patent_title] => Enhanced active agents
[patent_app_type] => utility
[patent_app_number] => 16/193407
[patent_app_country] => US
[patent_app_date] => 2018-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 35
[patent_no_of_words] => 25138
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 296
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16193407
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/193407 | Enhanced active agents | Nov 15, 2018 | Issued |
Array
(
[id] => 19506031
[patent_doc_number] => 12117447
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-10-15
[patent_title] => Metal nanoparticles and methods of making same
[patent_app_type] => utility
[patent_app_number] => 16/761473
[patent_app_country] => US
[patent_app_date] => 2018-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 28479
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 235
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16761473
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/761473 | Metal nanoparticles and methods of making same | Nov 1, 2018 | Issued |
Array
(
[id] => 16288941
[patent_doc_number] => 10765764
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-09-08
[patent_title] => Probes for imaging huntingtin protein
[patent_app_type] => utility
[patent_app_number] => 16/172425
[patent_app_country] => US
[patent_app_date] => 2018-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 6
[patent_no_of_words] => 22775
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16172425
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/172425 | Probes for imaging huntingtin protein | Oct 25, 2018 | Issued |
Array
(
[id] => 16267425
[patent_doc_number] => 20200268912
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-27
[patent_title] => COMPOSITE PARTICLES FOR IMAGING, METHOD FOR PRODUCING COMPOSITE PARTICLES, CELLS, CELL STRUCTURE, AND MIXED DISPERSION
[patent_app_type] => utility
[patent_app_number] => 16/761148
[patent_app_country] => US
[patent_app_date] => 2018-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11358
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16761148
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/761148 | COMPOSITE PARTICLES FOR IMAGING, METHOD FOR PRODUCING COMPOSITE PARTICLES, CELLS, CELL STRUCTURE, AND MIXED DISPERSION | Oct 18, 2018 | Abandoned |
Array
(
[id] => 16205008
[patent_doc_number] => 20200237998
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-30
[patent_title] => SYSTEM AND METHOD TO PROVIDE A CONTRAST AGENT
[patent_app_type] => utility
[patent_app_number] => 16/756433
[patent_app_country] => US
[patent_app_date] => 2018-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12023
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16756433
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/756433 | SYSTEM AND METHOD TO PROVIDE A CONTRAST AGENT | Oct 17, 2018 | Abandoned |
Array
(
[id] => 19666170
[patent_doc_number] => 12178891
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-12-31
[patent_title] => Methods and systems for producing, using, and administering hyperpolarized fluids
[patent_app_type] => utility
[patent_app_number] => 16/753875
[patent_app_country] => US
[patent_app_date] => 2018-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 32
[patent_no_of_words] => 15447
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 113
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16753875
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/753875 | Methods and systems for producing, using, and administering hyperpolarized fluids | Oct 4, 2018 | Issued |
Array
(
[id] => 14230321
[patent_doc_number] => 20190127333
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-02
[patent_title] => CONTRAST AGENTS FOR MYOCARDIAL PERFUSION IMAGING
[patent_app_type] => utility
[patent_app_number] => 16/143748
[patent_app_country] => US
[patent_app_date] => 2018-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29021
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16143748
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/143748 | Contrast agents for myocardial perfusion imaging | Sep 26, 2018 | Issued |
Array
(
[id] => 15646897
[patent_doc_number] => 20200085978
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-19
[patent_title] => COMPOSITION FOR CROSS TALK BETWEEN ESTROGEN RECEPTORS AND CANNABIONOID RECEPTORS
[patent_app_type] => utility
[patent_app_number] => 16/131045
[patent_app_country] => US
[patent_app_date] => 2018-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6911
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16131045
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/131045 | Composition for cross talk between estrogen receptors and cannabinoid receptors | Sep 13, 2018 | Issued |
Array
(
[id] => 17602530
[patent_doc_number] => 11330999
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-05-17
[patent_title] => Hyperpolarized and deuterium exchanged hyperpolarized
[patent_app_type] => utility
[patent_app_number] => 16/646549
[patent_app_country] => US
[patent_app_date] => 2018-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 14
[patent_no_of_words] => 10784
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16646549
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/646549 | Hyperpolarized and deuterium exchanged hyperpolarized | Sep 9, 2018 | Issued |
Array
(
[id] => 15813843
[patent_doc_number] => 10632078
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-04-28
[patent_title] => Rapidly disintegrating gelatinous coated tablets
[patent_app_type] => utility
[patent_app_number] => 16/116216
[patent_app_country] => US
[patent_app_date] => 2018-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 3
[patent_no_of_words] => 10172
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 149
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16116216
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/116216 | Rapidly disintegrating gelatinous coated tablets | Aug 28, 2018 | Issued |